A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Inferred to overlap with: Df(2L)BSC340.
Heterozygous Df(2L)BSC892 females are sterile.
The breakpoints of Df(2L)BSC892 predicted from the Release 5 genomic coordinates of the progenitor P{XP}d08229 and PBac{WH}loqsf00791 transposable element insertion sites are 2L:13060152 ;13382714 and the cytological breakpoints predicted from these coordinates are 34A5;34B9.